Epoetin-alfa improves interferon/ribavirin-associated anaemia
2 April 2004. Related: Conference reports, Hepatitis coinfection.
Hepatitis coinfection
International panel issues new guidelines for the care of HIV-HCV coinfected patients
2 April 2004. Related: Hepatitis coinfection.
NICE approves pegylated interferon plus ribavirin in UK
2 April 2004. Related: Hepatitis coinfection.
London study finds sexual and intranasal transmission of HCV
3 February 2004. Related: Hepatitis coinfection.
HCV-coinfection is associated with diabetes and CD4 decline
3 February 2004. Related: Hepatitis coinfection.
Hepatitis coinfection: incidence in Europe and response to transplant
1 December 2003. Related: Conference reports, Hepatitis coinfection.
UK guidelines for treating coinfection with HIV and hepatitis B or C published online
1 December 2003. Related: Hepatitis coinfection.
Kidney and liver transplantation in HIV-infected patients: case presentations and review
1 December 2003. Related: Hepatitis coinfection.
London epidemic of sexually transmitted hepatitis C
1 December 2003. Related: Hepatitis coinfection.
Coinfected patients may require longer HCV treatment, irrespective of genotype
1 November 2003. Related: Hepatitis coinfection.
Time on anti-HIV therapy is a protective factor for liver fibrosis in HIV-HCV coinfected patients
1 October 2003. Related: Hepatitis coinfection.
HIV-HCV co-infected patients have poorer response to HCV therapy
1 October 2003. Related: Hepatitis coinfection.
HIV coinfection, reinfection and superinfection
1 September 2003. Related: Conference reports, Hepatitis coinfection, HIV prevention and transmission, Drug resistance.
Hepatitis A vaccine provides affordable protection in HIV-positive individuals
1 July 2003. Related: Hepatitis coinfection.
PEG-interferon alfa-2b plus ribavirin for treatment of CHC patients who failed or relapsed following interferon-based therapy
1 July 2003. Related: Hepatitis coinfection.
Pegylated interferon plus ribavirin improves fibrosis in non-responders to standard interferon therapy
1 July 2003. Related: Hepatitis coinfection.
Coinfection: Hepatitis coverage from the Digestive Disease Week Conference
1 July 2003. Related: Hepatitis coinfection, On the web.
Genotype, enzyme levels, and viral load are clues to hepatitis C virus outcomes
1 June 2003. Related: Hepatitis coinfection.
Adherence and mental side effects during HCV treatment with interferon alfa and ribavirin in psychiatric risk groups
1 June 2003. Related: Hepatitis coinfection.
Key to hepatitis C virus persistence found
1 June 2003. Related: Hepatitis coinfection.
Co-infection: liver transplantation in HIV-positive persons
1 June 2003. Related: Hepatitis coinfection, On the web.
BHIVA HIV/hepatitis B and HIV/hepatitis C co-infection guidelines (2003): posted to web for consultation
1 May 2003. Related: Hepatitis coinfection.
Index of biochemical markers could reduce need for biopsy by half in HIV/HCV co-infected patients
1 May 2003. Related: Hepatitis coinfection.
HCV protects against abnormal blood lipids in HAART-treated HIV patients
1 May 2003. Related: Hepatitis coinfection.
HCV levels in semen
1 May 2003. Related: Hepatitis coinfection.
Low dose 200/100 IDV/RTV managed by TDM in substudy of co-infected patients
1 April 2003. Related: Conference reports, PK and drug interactions, Hepatitis coinfection.
12-week response predicts which HIV-HCV coinfected patients will not benefit from continued pegylated interferon plus ribavirin
1 April 2003. Related: Conference reports, Hepatitis coinfection.
Pegylated interferon associated with eye disorders
1 April 2003. Related: Conference reports, Side effects, Hepatitis coinfection.
European approval of adefovir for hepatitis B
1 April 2003. Related: Hepatitis coinfection, Other news.
Hepatitis C virus viraemia in HIV-positive individuals with negative HCV antibody tests
1 March 2003. Related: Hepatitis coinfection.
Roche’s Copegus (ribaviran) available in UK for use in the treatment of Hepatitis C
1 March 2003. Related: Hepatitis coinfection.
PEG-Intron plus ribavirin in non-responders and relapsers
1 March 2003. Related: Hepatitis coinfection.
Dangers of HIV/hepatitis B coinfection
1 March 2003. Related: Hepatitis coinfection.
The advantages of fosamprenavir; comparing saquinavir/r to lopinavir/r; reducing viral load to <3 copies; AZT-d4T cross resistance; and rising HCV rates
1 February 2003. Related: Conference reports, Antiretrovirals, Treatment strategies, Hepatitis coinfection, Drug resistance.
Low dose pegylated interferon is ineffective in treating HIV/HCV co-infected patients
9 January 2002. Related: Conference reports, Hepatitis coinfection.
Daily injection more effective than thrice-weekly interferon alpha-2b for HCV/HIV
2 November 2001. Related: Hepatitis coinfection.
Early treatment with interferon alpha-2b can prevent chronic liver disease in those with hepatitis C
1 October 2001. Related: Hepatitis coinfection.
Harmless hepatitis-type virus seems to extend lives of HIV-positive individuals
1 October 2001. Related: Hepatitis coinfection.
Adefovir dipivoxil promising for lamivudine-resistant HBV in HIV-1 infected patients
1 October 2001. Related: Hepatitis coinfection.
Severe hepatic injury common after HAART initiation
1 October 2001. Related: Side effects, Hepatitis coinfection.
HCV coinfection may have role in changes in body composition in HIV patients
1 September 2001. Related: Side effects, Lipodystrophy and metabolic complications, Hepatitis coinfection.
HIV/HCV coinfection: amid swirling controversy the profile of a killer emerges
17 May 2001. Related: Hepatitis coinfection.
French study finds low death rate due to hepatitis C virus in HIV-positive patients
17 May 2001. Related: Hepatitis coinfection.
Solid organ transplant in HIV/hepatitis co-infected patients
17 March 2001. Related: Conference reports, Hepatitis coinfection.
HIV protease inhibitors associated with hepatic cytolysis
17 January 2001. Related: Side effects, Hepatitis coinfection.
Lamivudine withdrawal may reactivate HBV in HIV-positive patients
17 January 2001. Related: Antiretrovirals, Hepatitis coinfection.
Treatment of HIV+ subjects co-infected with hepatitis B or C: safety and efficacy comparison of ABT 378/r versus nelfinavir from a phase III blinded randomised clinical trial
17 December 2000. Related: Conference reports, Hepatitis coinfection.
Interferon-alpha and ribavarin therapy for hepatitis C in HIV coinfected patients
17 December 2000. Related: Conference reports, Hepatitis coinfection.
Lack of significant viral load alterations of hepatitis B virus (HBV) and hepatitis C virus (HCV) during treatment with interleukin-2 and HAART
17 December 2000. Related: Conference reports, Hepatitis coinfection.
Opportunistic illness and viral hepatitis co-infection
17 October 2000. Related: Conference reports, Coinfections and complications, Hepatitis coinfection.